Serous tumors of the ovary (borderline tumors and carcinomas) with and without micropapillary features

International Journal of Gynecological Pathology

Volumn 22, Issue 1, 2003, Pages 25-28

  Prat, Jaime ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CLINICAL FEATURE; EDITORIAL; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROPAPILLARY TUMOR; ONCOGENE K RAS; OVARY CARCINOMA; OVARY TUMOR; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SEROUS TUMOR;

CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; OVARIAN NEOPLASMS; PROGNOSIS;

EID: 0037216476     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200301000-00007     Document Type: Editorial

References (21)

1. Gilks CB, Alkushi A, Yue J, et al. Advanced stage serous borderline tumors of the ovary: A clinicopathological study of 49 cases. Int J Gynecol Pathol 2003;22:29-36.
2. Singer G, Shih I-M, Truskinowski A, et al. Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: Invasive MPSC (a low-grade tumor) and conventional serous carcinoma (a high-grade tumor). Int J Gynecol Pathol 2003;22:37-41.
3. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
4. Serov SF, Scully RE, Sobin LH. Histological Typing of Ovarian Tumours. Geneva: World Health Organization, 1973.
5. McCaughey WT, Kirk ME, Lester W, et al. Peritoneal epithelial lesions associated with proliferative serous tumors of ovary. Histopathology 1984;8:195-208.
6. Bell DA, Weinstock MA, Scully RE. Peritoneal implants of serous borderline tumors: Histologic features and prognosis. Cancer 1988; 62:2212-22.
7. De Nictolis M, Montironi R, Tommasoni S, et al. Serous borderline tumors of the ovary: A clinicopathologic, immunohistochemical and quantitative study of 44 cases. Cancer 1992;70:152-60.
8. Seidman JD, Kurman RJ. Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol 1996;20:1331-45.
9. Eichhorn JH, Bell DA, Young RH, et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns. A study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397-409.
10. Prat J, de Nictolis M. Serous borderline tumors of the ovary. A long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111-28.
11. Burks RT, Sherman ME, Kurman RJ. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319-30.
12. Slomovitz BM, Caputo TA, Gretz HF III, et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002;26:592-600.
13. Deavers MT, Gershenson DM, Tortolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential. A study of 99 advanced stage cases. Am J Surg Pathol 2002;26:1129-41.
14. Bell KA, Smith Sehdev AE, Kurman RJ. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas. Am J Surg Pathol 2001;25:419-32.
15. Bell DA, Scully RE. Early de novo ovarian carcinoma: A study of fourteen cases. Cancer 1994;73:1859-64.
16. Singer G, Kurman RJ, Chang H-W, et al. Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 2002;160:1223-8.
17. Bos JL. ras oncogene in human cancer: A review. Cancer Res 1989;49:4682-9.
18. Tabata T, Fujimori T, Maeda S, et al. The role of ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis. Int J Pancreatol 1994;14:237-44.
19. Cuatrecasas M, Villanueva A, Matias-Guiu X, et al. K-ras mutations in ovarian mucinous tumors: A clinicopathologic and molecular study of 95 cases. Cancer 1997;79:1581-6.
20. Cuatrecasas, M, Erill, N, Musulen, E, et al. K-ras Mutations in non-mucinous ovarian epithelial tumors: A molecular analysis and clinicopathological study of 144 patients. Cancer 1998;82:1088-95.
21. Vogelstein B, Kinzler KW. Digital PCR. Proc Natl Acad Sci U S A 1999;96:9236-41.